William Harrington
QuietNamed in filings at Osage University PartnersOn the current fund
- Board seats filed
Named in filings at Osage University PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| MicroTransponder | Medical devices | June 2022 | OUP, U.S Venture Partners |
| MediSix Therapeutics | Biotech & pharma | September 2019 | Lightstone Ventures, OUP |
| Neuros Medical | Medical devices | August 2017 | Aperture, OUP, U.S Venture Partners |
| Hyalex Orthopaedics | Medical devices | May 2017 | OUP, Treo Ventures |
| Atterocor | Biotech & pharma | December 2015 | OUP |
| Ribon Therapeutics | Biotech & pharma | November 2015 | OUP, U.S Venture Partners |
| Runa | Fintech | October 2014 | OUP |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name William Harrington on the board, based on 7 filed seats with a verified or cited source.